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ity by up to 21%.2
While the use of FOBT is supported by
Level I evidence, other screening methods,
such as flexible sigm idosc py and colono-
scopy, are the subject of ongoing evaluation,
and it remains to be seen whether they will








Objective:  To evaluate the outcomes 10 years after a flexible sigmoidoscopy colorectal 
cancer (CRC) screening program in asymptomatic average-risk individuals.
Design, setting and patients:  In 1995, a program of flexible sigmoidoscopy-based 
screening of asymptomatic average-risk individuals aged 55–64 years was established 
at Fremantle Hospital, Western Australia. Insertion depths, pathological findings and 
ct-rated pain scores have been prospectively recorded. A follow-up flexible 
oidoscopy examination was offered to attendees 5 years after the initial screening. 
screening malignancies were determined by linkage with the Western Australian 
er Registry in September 2006.
 outcome measures:  Yield of neoplasia at initial and follow-up sigmoidoscopy, 
he incidence of CRC detected after screening.
lts:  Between 1995 and 2005, 3402 people underwent an initial flexible 
sigmoidoscopy screening examination (mean age, 60 years; women, 41%) and 1025 
had a 5-year recall examination. Mean insertion depth was greater in men than women 
(60 cm v 52 cm, P < 0.001). The insertion depth in women was more likely to be < 40 cm 
(17% v 6%, P < 0.001). Mean pain score was 2.9 for men and 4.0 for women (P < 0.001). 
Fourteen per cent of initial screenings detected at least one adenoma. Over a mean 
follow-up time of 8 years, invasive CRC was detected by flexible sigmoidoscopy 
screening in 0.4% of participants; 0.7% of those with a normal result of screening 
later developed CRC, with 75% of these found proximal to the splenic flexure.
Conclusions:  Flexible sigmoidoscopy is a viable screening method, with well defined 
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utility and limitations, for CRC screening of asymptomatic people with average risk.olo
ing
traC rectal cancer is the second lead- cause of cancer death in Aus-l ia.1  Evidence from large,
randomised controlled studies of biennial
guaiac-based faecal occult blood testing
(FOBT) indicates that this screening method
can reduce colorectal cancer (CRC) mortal-
National Health and Medical Research
Council currently includes 5-yearly flexible
sigmoidoscopy as an alternative screening
method.3 Case–control studies have shown
that sigmoidoscopy screening can reduce
the risk of subsequent fatal distal CRC by up
to 60%, and reduce by approximately 30%
overall CRC mortality.4,5 Randomised con-
trolled trials currently underway will pro-
vide evidence of the magnitude of benefit of
flexible sigmoidoscopy screening.6-8
Fremantle Hospital, in Western Australia,
has been conducting a community-based
screening program for CRC using flexible
sigmoidoscopy since 1995. Here, we review
the 10-year outcomes of the screening pro-
gram, assessing in particular CRC detected
and incidence of later malignancy.
METHODS
Patients and methods
In 1995, a flexible sigmoidoscopy-based
CRC screening program for asymptomatic,
average-risk individuals aged 55–64 years
was established at Fremantle Hospital. Let-
ters of invitation were sent to eligible people
identified from the Western Australian Elec-
toral Roll. Participation from volunteers was
also accepted. The methods and progress
results of the screening program have been
reported previously.9,10 Our study includes
participant data up to the end of July 2005.
Outpatient flexible sigmoidoscopy
screening was performed, without sedation,
after phosphate enema. The procedures
were performed by gastroenterologists and
surgeons, or by supervised registrars and
general practitioners, using a standard
colonoscope, with air or carbon dioxide
insufflation. Participants were asked to rate
the pain experienced during the procedure
on a visual analogue scale of increasing pain
from 0 to 10.
Biopsies were taken of polyps identified by
sigmoidoscopy, and patients with proven ade-
nomas were advised to have a colonoscopy.
An advanced lesion was defined as (i) any
adenoma >10mm in size; (ii) any adenoma
with villous histological features; or (iii) high-
grade dysplasia or invasive CRC. Colono-
scopy was arranged after liaison with the
general practitioner, and the results of these
procedures were obtained for most patients.
From the year 2000 onwards, participants
with initially normal results (normal or
hyperplastic polyps only) of the examina-
tion have been recalled after 5 years. Partici-
pants were sent invitations for a follow-up
flexible sigmoidoscopy screening, and
phone contact was made to confirm contin-
ued eligibility for screening. Follow-up pro-
cedures were performed by the same staff
and using the same methods as for the initial
examinations.
Cancer outcomes
Linkage of the screening cohort to the West-
ern Australian Cancer Registry was per-
formed in September 2006, with approval of
the South Metropolitan Health Service
Human Research Ethics Committee. Date of
diagnosis with CRC and location of the
cancer were obtained. A proximal CRC was
defined as being proximal to or including
the splenic flexure, and a distal one as being
located in the rectum, sigmoid or descend-
ing colon. Only CRC data coded as invasive
and based on histological verification were
included.
Statistical analysis
Our findings are presented descriptively
with analysis of univariate factors performed
by χ2 testing for categorical variables and
analysis of variance (ANOVA) (SPSS, version
11.0, SPSS Inc, Chicago, Ill, USA). Risk
ratios were calculated comparing the patho-
logical findings at the initial and follow-up
sigmoidoscopy screening. To examine vari-
ables predicting adenoma detection at the
initial or follow-up screening, a multinomialJA • Volume 187 Number 5 • 3 September 2007
R ESEARCHregression model was constructed using the
variables: age, sex, insertion depth, pain
score, proceduralist seniority and training
background, bowel preparation quality, and
findings at initial sigmoidoscopy. Variables
with a bivariate association at P < 0.2 were
selected for inclusion in the model. Simi-
larly, a model was constructed to examine
factors predictive of diagnosis of later CRC,
if sigmoidoscopy results were normal.
RESULTS
Initial screening
Between July 1995 and July 2005, 3402
initial flexible sigmoidoscopy screening
examinations were performed. The mean
age of participants was 60 years (range, 53–
70 years) and 41% were women. The
response rate in the first 5 years (initial
phase) of the program was estimated at
23%.10 Volunteers accounted for 43% of
those attending initial screening.
Mean sigmoidoscope insertion depth for
men was 60 cm compared with 52 cm for
women (P < 0.001). Compared with men,
the insertion depth for women was more
likely to be less than 40 cm (17% v 6%,
P < 0.001), and women were less likely to
have an insertion depth of 50 cm or greater
(63% v 80%, P < 0.001). The mean pain
score was 2.9 for men and 4.0 for women
(P < 0.001). Satisfactory bowel preparation
was reported in 93% of men and 92% of
women. A summary of the findings is given
in Box 1. No cases of significant bleeding or
perforation were reported during the screen-
ing period.
Overall, the adenoma detection rate was
14%. Advanced adenomas were detected in
5% of procedures. Men were significantly
more likely to have a lesion detected than
women. Invasive CRC was ultimately diag-
nosed in 11/1992 men (0.6%) and 1/1410
women (0.1%) (P = 0.09).
Recall screening
From September 2000 to July 2005, follow-
up screening was performed in 1025 people.
The mean interval from the time of initial
screening was 5.2 years. These results are
also given in Box 1. Of the 2270 partici-
pants who had initial flexible sigmoido-
scopy screening between 1995 and 1999
and were eligible for the 5-year follow-up
screening, 958 (42%) attended after an
invitation for follow-up screening. The rela-
tive risk (RR) of finding any neoplasia at the
recall screening (compared with the initial
screening) was reduced, but the difference
was not significant (RR, 0.8; 95% CI, 0.6–
1.0); the likelihood of finding advanced
neoplasia was more substantially reduced
(RR, 0.4; 95% CI, 0.3–0.6). Up to July
2005, no CRC was detected by routine
follow-up screening.
Predictors of neoplasia at initial and 
follow-up screening
On multinomial regression analysis, age
over 60 years (odds ratio [OR], 1.3; 95% CI,
1.1–1.6), male sex (OR, 2.0; 95% CI 1.6–
2.6) and good bowel preparation (OR, 2.4;
95% CI, 1.6–4.1) were significant inde-
pendent predictors of an adenoma. At the
recall screening, only male sex was a signifi-
cant predictor of adenoma (OR, 2.1; 95% CI
1.3–3.3).
Cancer findings
As a result of initial screening and subse-
quent colonoscopy, a total of 13 invasive
malignancies (0.4% of participants) were
diagnosed. Ten derived from a lesion identi-
fied by sigmoidoscopy, and two new rectal
malignancies and one proximal malignancy
were detected at follow-up colonoscopy.
Thus, flexible sigmoidoscopy found the
index lesions in 12 patients with advanced
adenoma and one with multiple small ade-
nomas. CRC staging data were available for
all lesions, with nine being Stage I, three
Stage III, and one Stage IV disease.
Linkage to the WA Cancer Registry in
September 2006 gave a mean follow-up
time of 8.2 years for the cohort. From the
2933 participants whose initial screening
had not shown any colorectal neoplasia,
invasive CRC had been recorded by the
Registry in 20 of these patients (0.7%).
Fifteen cancers appear to have been located
proximal to the splenic flexure and five were
distal. In men, the CRC incidence was 0.6%
(0.4% proximal, 0.2% distal), and in women
the incidence was 0.8% (0.6% proximal,
0.2% distal), although these sex differences
were not statistically significant. Of these 20
patients, 18 had attended only the initial
flexible sigmoidoscopy screening. Of the
two who had also attended the 5-year fol-
low-up sigmoidoscopy, one was a 62-year-
old woman who had developed iron defi-
ciency anaemia 12 months before the fol-
low-up screening, but had not attended an
arranged colonoscopy. CRC stage data were
available for 11 patients, with two being
Stage I, one Stage II, five Stage III, and three
Stage IV disease.
The mean time from flexible sigmoido-
scopy screening to later CRC diagnosis was
4.1 years (range, 0.2–8.6 years), and, as
mentioned above, no CRC was found at
routine follow-up sigmoidoscopy during the
study period. Of five patients with distal
malignancy, the mean time to CRC diagnosis
after sigmoidoscopy was 2.7 years, with
only one of these occurring within 2 years of
1 Summary of the findings of the initial and follow-up flexible sigmoidoscopy 
examinations
Men Women Total P *
Initial sigmoidoscopy n = 1992 n = 1410 n = 3402
Mean insertion depth (cm) 60 52 57 < 0.001
Mean pain score (scale of 0–10) 2.9 4.0 3.4 < 0.001
Proportion with:†
Normal findings 61% 75% 67% < 0.001
Any neoplasia 17% 10% 14% < 0.001
Advanced neoplasia 6.4% 3% 5% < 0.001
Invasive colorectal cancer‡ 0.6% 0.1% 0.4% 0.09
5-year follow-up sigmoidoscopy n = 639 n = 386 n = 1025
Mean insertion depth (cm) 62 52 58 < 0.001
Proportion with:†
Normal findings 65% 75% 70% 0.001
Any neoplasia 14% 6.5% 11% < 0.001
Advanced neoplasia 2.8% 1.0% 2.1% 0.07
Invasive colorectal cancer 0 0 0 0
* For difference between the sexes. † Percentages do not equal 100%, as some cases with minor histological 
abnormalities are not included. ‡ After follow-up colonoscopy. ◆MJA • Volume 187 Number 5 • 3 September 2007 275
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proximal cancers was 4.4 years, with only
two of the 15 diagnosed within 2 years. Data
for these patients are summarised in Box 2.
When distal post-screening cancers only
were assessed, then poor bowel preparation
(compared with satisfactory preparation)
was a significant predictor of CRC risk (OR,
7.2; 95% CI, 1.2–43.6). When proximal
post-screening cancers only were consid-
ered, then an insertion depth of  30 cm
(compared with deeper insertion) showed a
trend to greater risk of later CRC (OR, 3.5;
95% CI, 1.0–12.4). However, when post-
screening cancers at all locations were con-
sidered, these associations were not present.
Combining data for cancers detected by
sigmoidoscopy screening with those
detected after screening allows estimation of
the sensitivity and negative predictive value
of flexible sigmoidoscopy (with follow-up of
any adenoma) for detecting or predicting
invasive CRC:
• for all patients with CRC diagnosed at
flexible sigmoidoscopy or within 2 years of
screening (by which time an invasive CRC
should have become clinically apparent),
sensitivity is 87% and negative predictive
value is 99.9%;
• for a 5-year period after flexible sig-
moidoscopy, the sensitivity of the test to
identify patients “at risk” of CRC falls to 48%
(75% for distal CRC; 9% for proximal CRC),
with a negative predictive value of 99.6%.
DISCUSSION
In this long-term study of flexible sig-
moidoscopy-based screening in average-risk
people, 55–64 years of age, 14% of those
attending the initial screening were diag-
nosed with neoplastic lesions and 0.4%
were subsequently found to have invasive
CRC. These data are consistent with
reported baseline findings of other large
flexible sigmoidoscopy screening trials.6,7 In
women, the sigmoidoscope insertion depth
tends to be less than in men, overall pain
scores are higher, and a lower rate of neopla-
sia is detected. The 23% uptake rate by
those mailed invitations for flexible sig-
moidoscopy screening in our study com-
p a r e s  w i t h  th e  14%  u p ta k e  f o r
sigmoidoscopy and FOBT screening in
another Australian study,11 and the 32%
uptake in an Italian cohort also for FOBT–
sigmoidoscopy screening.12
Cancers detected by screening tend to be
at an early stage (nine of 13 were Stage I).
While our data are incomplete, those diag-
nosed later after a normal flexible sig-
moidoscopy result tended to be more
advanced (73% Stage III or IV). This may
reflect a greater burden of proximal and
often asymptomatic cancer in this group. In
a large colorectal cancer series of public
hospital patients in WA, 16% overall pre-
sented as Stage I, while 48% presented as
Stage III or IV.13
After an average of 8 years’ follow-up,
0.7% of participants who had received a
normal screening result were later diagnosed
with CRC. Seventy-five per cent of these
cancers were proximal. The potential miss
rate of flexible sigmoidoscopy remains a
contentious issue. Multiple studies support
the likelihood that 2%–5% of asymptomatic
individuals will have isolated proximal
advanced neoplasia.14-16 We found that
invasive CRC at any site was unlikely within
2 years of a negative result of flexible sig-
moidoscopy, with a sensitivity of 87% and a
negative predictive value of 99.9% (which
partly reflects that CRC is still uncommon in
people aged 55–64 years). Sensitivity falls to
48% for identifying those at risk of CRC
within 5 years. The sensitivity of one immu-
nochemical FOBT for detecting current
invasive CRC was 66% in a study in which
all participants also received colonoscopy.17
The negative predictive value for cancer in
this study was 99.9%; that is, 0.1% of
patients with a negative result of an FOBT
actually had CRC.
While colonoscopy may be considered
the “gold standard” for bowel examination,
it too has a false negative rate. Several
studies have documented CRC being diag-
nosed after colonoscopy.18-20 A WA study of
cancer after a negative colonoscopy result
found a 0.5% incidence of CRC within 5
years.21 As such, the incremental benefit of
colonoscopy over flexible sigmoidoscopy
may be smaller than anticipated.
Our data have some limitations. The
screening group is a heterogeneous mix of
people responding to a mailed invitation
and a large contingent of volunteers from
the community, and there is no prospec-
tively recruited control group with which to
compare outcomes. Modelling by the WA
Cancer Registry based on age-specific rate
data suggests that the expected incidence of
CRC in an equivalently aged cohort over a
similar time period would be 45 cases (com-
pared with our total of 33).22 Our cohort
represents those at average CRC risk,
whereas the general population contains a
mix of average and above average risk (fam-
ily history of CRC, etc).
The strengths of our study are in its use of
biopsy to confirm whether polyps were neo-
plastic, and being able to reliably capture
CRC outcomes by using the WA Cancer
Registry and its data linkage capabilities.
In summary, our 10-year study of flexible
sigmoidoscopy shows that this screening
method remains a viable screening tool and
provides important data for determining the
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